Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.
about
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Interpretability of Cancer Cli ...... ternative to the Hazard Ratio.
@en
Interpretability of Cancer Cli ...... ternative to the Hazard Ratio.
@nl
type
label
Interpretability of Cancer Cli ...... ternative to the Hazard Ratio.
@en
Interpretability of Cancer Cli ...... ternative to the Hazard Ratio.
@nl
prefLabel
Interpretability of Cancer Cli ...... ternative to the Hazard Ratio.
@en
Interpretability of Cancer Cli ...... ternative to the Hazard Ratio.
@nl
P2093
P2860
P1433
P1476
Interpretability of Cancer Cli ...... ternative to the Hazard Ratio.
@en
P2093
Brian Claggett
Dae Hyun Kim
Hajime Uno
Kyongsun Pak
Lee-Jen Wei
Masahiro Takeuchi
Robert C Kane
P2860
P304
P356
10.1001/JAMAONCOL.2017.2797
P577
2017-09-21T00:00:00Z